Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An ovarian mature teratoma characterized by the presence of aberrant thyroid tissue with morphologic changes identical to thyroid carcinoma. Patients may present with abdominal mass and unusual symptoms due to thyrotoxicosis, or with Meigs syndrome (ascites and pleural effusion).
Data assembled from 1 of 12 sources · Last updated Sep 19, 2026, 6:43 AM UTC
AI-curated news mentioning malignant struma ovarii
Updated Feb 23, 2026
A new study outlines optimal strategies for the surgical and long-term management of malignant struma ovarii, a rare ovarian tumor. The findings aim to improve treatment outcomes for affected patients.
Recent research highlights advances in understanding the molecular pathogenesis and classification of malignant struma ovarii, which may improve diagnosis and treatment strategies. This study provides insights into the complexities of this rare ovarian tumor.